Connor, Bradley A.
Rogova, Marina
Garcia, Jefferson
Gardner, Morgan
Waraich, Charandeep
Averill, Victoria
Funding for this research was provided by:
Cosmo Pharmaceuticals
Article History
Received: 30 September 2024
Accepted: 19 March 2025
First Online: 3 April 2025
Declarations
:
: This study was approved by Advarra Institutional Review Board on October 2, 2019, with protocol # PRO00038302. All study subjects received and signed an informed consent form prior to participating in the study.
: Not applicable.
: 4. We confirm that this work, including VAS questionnaires (VAS1-3) included in this protocol is original, has not been previously published elsewhere, and is not under consideration by another journal or book (print or electronic). All VAS questionnaires used in our study were developed for this study and have not been previously published elsewhere.
: The authors declare no competing interests.